Cognitive control modulates preferential sensory processing of affective stimuli

Adaptive human behavior crucially relies on the ability of the brain to allocate resources automatically to emotionally significant stimuli. This ability has consistently been demonstrated by studies showing preferential processing of affective stimuli in sensory cortical areas. It is still unclear, however, whether this putatively automatic mechanism can be modulated by cognitive control processes. Here, we use functional magnetic resonance imaging (fMRI) to investigate whether preferential processing of an affective face distractor is suppressed when an affective distractor has previously elicited a response conflict in a word-face Stroop task. We analyzed this for three consecutive stages in the ventral stream of visual processing for which preferential processing of affective stimuli has previously been demonstrated: the striate area (BA 17), category-unspecific extrastriate areas (BA 18/19), and the fusiform face area (FFA). We found that response conflict led to a selective suppression of affective face processing in category-unspecific extrastriate areas and the FFA, and this effect was accompanied by changes in functional connectivity between these areas and the rostral anterior cingulate cortex. In contrast, preferential processing of affective face distractors was unaffected in the striate area. Our results indicate that cognitive control processes adaptively suppress preferential processing of affective stimuli under conditions where affective processing is detrimental because it elicits response conflict

A note on quantum structure constants

The Cartan-Maurer equations for any $q$-group of the $A_{n-1}, B_n, C_n, D_n$ series are given in a convenient form, which allows their direct computation and clarifies their connection with the $q=1$ case. These equations, defining the field strengths, are essential in the construction of $q$-deformed gauge theories. An explicit expression \om ^i\we \om^j= -\Z {ij}{kl}\om ^k\we \om^l for the $q$-commutations of left-invariant one-forms is found, with \Z{ij}{kl} \om^k \we \om^l \qonelim \om^j\we\om^i.Comment: 9 pp., LaTe

A telecom-wavelength quantum repeater node based on a trapped-ion processor

A quantum repeater node is presented based on trapped ions that act as single photon emitters, quantum memories and an elementary quantum processor. The node's ability to establish entanglement across two 25 km-long optical fibers independently, then to swap that entanglement efficiently to extend it over both fibers, is demonstrated. The resultant entanglement is established between telecom-wavelength photons at either end of the 50 km channel. The system improvements to allow for repeater-node chains to establish stored entanglement over 800 km at Hertz rates are calculated, revealing a near-term path to distributed networks of entangled sensors, atomic clocks and quantum processors.Comment: 5 pages and 4 figures main text plus supplementar

A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors

PURPOSE: MET gene amplification is associated with poor prognosis in gastric/gastroesophageal junction/esophageal (G/GEJ/E) cancers. We determined antitumor activity, safety, and pharmacokinetics of the small-molecule MET inhibitor AMG 337 in MET-amplified G/GEJ/E adenocarcinoma or other solid tumors.Patients and Methods: In this phase II, single-arm study, adults with MET-amplified G/GEJ/E adenocarcinoma (cohort 1) or other MET-amplified solid tumors (cohort 2) received AMG 337 300 mg/day orally in 28-day cycles. The primary endpoint was objective response rate (ORR; cohort 1). Secondary endpoints included ORR (cohort 2), progression-free survival (PFS), overall survival (OS), and safety. RESULTS: Of 2101 patients screened for MET amplification, 132 were MET-amplified and 60 were enrolled: 45 in cohort 1, and 15 in cohort 2. Fifty-six patients (97%) had metastatic disease; 57 had prior lines of therapy (1 prior line, 29%; ≥2 prior lines, 69%). A protocol-permitted review showed efficacy that was lower-than-expected based on preliminary data from a first-in-human study, and enrollment was stopped. Fifty-eight patients received ≥1 AMG 337 dose. ORR in cohort 1 was 18% (8 partial responses). No responses were observed in cohort 2. Of 54 evaluable patients, median (95% CI) PFS and OS were 3.4 (2.2-5.0) and 7.9 (4.8-10.9) months, respectively. The most frequent adverse events (AEs) were headache (60%), nausea (38%), vomiting (38%), and abdominal pain, decreased appetite, and peripheral edema (33% each); 71% had grade ≥3 AEs and 59% had serious AEs. CONCLUSIONS: AMG 337 showed antitumor activity in MET-amplified G/GEJ/E adenocarcinoma but not in MET-amplified non-small-cell lung cancer.See related commentary by Ma, p. 2375. ispartof: CLINICAL CANCER RESEARCH vol:25 issue:8 pages:2414-2423 ispartof: location:United States status: publishe

Obsessive Compulsive Behaviors in Children with Developmental Disabilities: A Function-based Conceptual Framework and Single-case Application

Repetitive behaviors are prevalent in a number of neurodevelopmental disorders including autism spectrum disorder (ASD) and intellectual disability (ID). A subset of repetitive behaviors found in ASD and ID can be topographically similar to symptoms in obsessive compulsive disorder (OCD). Through two manuscripts in preparation (Chapters 2 and 4), this project aims to discuss a function-based approach to conceptualizing, assessing, and treating obsessive compulsive behaviors (OCBs) in ASD and ID. The first manuscript is a conceptual paper responding to the variety of approaches researchers use to categorize the behaviors (i.e., assigning a comorbid diagnosis or acknowledging overlapping symptoms of ASD). To date, a clear consensus has not yet been reached amongst the researchers in this field. This paper builds on the differential diagnosis guidelines of the DSM-5 and clinical experts in the field by providing a multidisciplinary, function-based approach to conceptualizing, assessing, and treating individual OCBs in ASD using clinical case examples. Obsessive compulsive behaviors can serve a variety of functions beyond the reduction of anxiety including automatic positive reinforcement or socially mediated reinforcement. The strengths of function-based treatment combined with cognitive behavioral therapy for working with complex obsessive compulsive behaviors in ASD are presented. A second manuscript demonstrates the applicability of this framework in a single case study of four-year-old boy with mild ID and obsessive compulsive behaviors. An intensive, adapted version of function-based cognitive behavioral therapy was administered in the boy’s preschool. The treatment successfully eliminated two OCBs while concomitantly teaching joint engagement with peers on work-related tasks. Results were maintained at a three-week follow- up. The implications of the treatment protocol, in addition to the broader importance of working from a multidisciplinary perspective for children with obsessive compulsive behaviors, are discussed

Express method for isolation of ready-to-use 3D chitin scaffolds from aplysina archeri (aplysineidae: verongiida) demosponge

Sponges are a valuable source of natural compounds and biomaterials for many biotechnological applications. Marine sponges belonging to the order Verongiida are known to contain both chitin and biologically active bromotyrosines. Aplysina archeri (Aplysineidae: Verongiida) is well known to contain bromotyrosines with relevant bioactivity against human and animal diseases. The aim of this study was to develop an express method for the production of naturally prefabricated 3D chitin and bromotyrosine-containing extracts simultaneously. This new method is based on microwave irradiation (MWI) together with stepwise treatment using 1% sodium hydroxide, 20% acetic acid, and 30% hydrogen peroxide. This approach, which takes up to 1 h, made it possible to isolate chitin from the tube-like skeleton of A. archeri and to demonstrate the presence of this biopolymer in this sponge for the first time. Additionally, this procedure does not deacetylate chitin to chitosan and enables the recovery of ready-to-use 3D chitin scaffolds without destruction of the unique tube-like fibrous interconnected structure of the isolated biomaterial. Furthermore, these mechanically stressed fibers still have the capacity for saturation with water, methylene blue dye, crude oil, and blood, which is necessary for the application of such renewable 3D chitinous centimeter-sized scaffolds in diverse technological and biomedical fields. © 2019 by the authors